Results 91 to 100 of about 75,921 (210)

The histone demethylase UTX regulates the lineage-specific epigenetic program of invariant natural killer T cells [PDF]

open access: yes, 2018
Invariant natural killer T cells (iNKT cells) are innate-like lymphocytes that protect against infection, autoimmune disease and cancer. However, little is known about the epigenetic regulation of iNKT cell development.
Barnitz, R Anthony   +16 more
core   +1 more source

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells

open access: yesFrontiers in Immunology, 2017
Invariant natural killer T (iNKT) cells represent a unique population of CD1d-restricted T lymphocytes expressing an invariant T cell receptor encoded by Vα14-Jα18 and Vα24-Jα18 gene segments in mice and humans, respectively.
Zoran V. Popovic   +7 more
doaj   +1 more source

The Role of Autophagy in iNKT Cell Development

open access: yesFrontiers in Immunology, 2018
CD1d-restricted invariant natural killer T (iNKT) cells are innate-like T cells that express an invariant T cell receptor (TCR) α-chain and recognize self and foreign glycolipid antigens.
Guan Yang, John P. Driver, Luc Van Kaer
doaj   +1 more source

Macrophage transactivation for chemokine production identified as a negative regulator of granulomatous inflammation using agent-based modeling [PDF]

open access: yes, 2018
Cellular activation in trans by interferons, cytokines and chemokines is a commonly recognized mechanism to amplify immune effector function and limit pathogen spread. However, an optimal host response also requires that collateral damage associated with
Andrews, Paul S.   +8 more
core   +5 more sources

Modulació del canvi d'isotip de les immunoglobulines per senyals del sistema immunitari innat [PDF]

open access: yes, 2014
Els limfòcits B madurs emergeixen del moll de l'os i continuen diversificant el seu repertori genètic d'immunoglobulines a través de dos processos que depenen de la presència d'antigen, la hipermutació somàtica (SHM, per les seves sigles en anglès) i el ...
Cerutti, Andrea   +2 more
core  

Stages versus subsets: Invariant Natural Killer T cell lineage differentiation [PDF]

open access: yesCytokine, 2015
Invariant Natural Killer T (iNKT) cells represent a population of innate T lymphocytes which act as 'first-responders' to infection. While they have long been considered a versatile cell, capable of secretion of multiple cytokines upon activation, recent evidence now indicates that distinct lineages of iNKT cells with unique transcriptional and ...
Heather M, Buechel   +2 more
openaire   +2 more sources

Natural killer cells and natural killer T cells in Lyme arthritis [PDF]

open access: yes, 2013
Introduction: Natural killer (NK) and natural killer T (NKT) cells provide a first line of defense against infection. However, these cells have not yet been examined in patients with Lyme arthritis, a late disease manifestation.
Drouin, Elise E   +2 more
core   +2 more sources

Modulatory Function of Invariant Natural Killer T Cells in Systemic Lupus Erythematosus

open access: yesClinical and Developmental Immunology, 2012
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease with complex immunological and clinical manifestations. Multiple organ failure in SLE can be caused by immune dysfunction and deposition of autoantibodies.
Yi-Ping Chuang   +4 more
doaj   +1 more source

The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8+ T Cell Generation [PDF]

open access: yes, 2015
New vaccination strategies focus on achieving CD8+ T cell (CTL) immunity rather than on induction of protective antibody responses. While the requirement of CD4+ T (Th) cell help in dendritic cell (DC) activation and licensing, and in CTL memory ...
Catherine Gottschalk   +2 more
core   +2 more sources

Dual-targeted CAR T-cell immunotherapies for hematological malignancies: latest updates from the 2023 ASH annual meeting

open access: yesExperimental Hematology & Oncology
Over the past few years, dual-targeted chimeric antigen receptor (CAR) T-cell therapy has been employed in the management of hematological malignancies to mitigate treatment failure, particularly in cases of antigen escape.
Jingyi Yang   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy